220
Participants
Start Date
August 18, 2021
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Multimodal, multi-parametric MRI
The investigators will use multimodal, multi-parametric sequences to investigate neuroinflammatory and neurodegenerative processes in vivo. Participants will be assessed three times over 2 years.
Immune and cytokine profiling
Blood samples will be collected for immune and cytokine profiling. Participants will be assessed three times over 2 years.
Neuropsychological testing
Participants will have neuropsychological testing three times over 2 years.
RECRUITING
Biotech Place, Winston-Salem
National Institute on Drug Abuse (NIDA)
NIH
Wake Forest University Health Sciences
OTHER